A notorious hacking group with ties to Russia’s intelligence network has been targeting COVID-19 vaccine developers, according to the United States, United Kingdom, and Canadian government. APT29, also known as ‘The Dukes’ or ‘Cozy Bear,’ has been organizing cyber attacks in an effort to steal confidential information regarding COVID-19 vaccine development and research, according to […] Continue reading ->
On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital.  The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading ->
It is still too early to tell how long immunity to SARS-CoV-2, the virus that causes COVID-19, may last after infection, the World Health Organization’s Technical Lead for COVID-19, Maria Van Kerkhove said at Monday press briefing. Van Kerkhove’s comments came just after the publication of a new study by researchers from Kings College, London, […] Continue reading ->
Just three days after almost 240 scientists criticized WHO for downplaying the risks of airborne transmission of tiny SARS-CoV-2 particles, or aerosols, the Organization edged closer to its critics point of view.    WHO’s latest scientific brief, published Thursday, acknowledges that “short-range aerosol transmission cannot be ruled out”. The tiny virus particles floating through the air […] Continue reading ->
A growing bloc of aerosol scientists, epidemiologists, and infectious disease experts are urging the World Health Organization to acknowledge that particles containing SARS-CoV-2, the virus that causes COVID-19, can remain suspended in the air for hours and be inhaled, potentially representing another route of transmission. Some 239 scientists from around the world urged the WHO […] Continue reading ->
The United States has secured almost all of Gilead Sciences’ projected production of remdesivir – an antiviral that was shown to reduce hospitalization times for COVID-19 patients- for the next three months. US Health and Human Services (HHS) has secured 100 percent of Gilead’s projected production for July (94,200 treatment courses), 90 percent of production […] Continue reading ->